Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Constanze Slabik"'
Autor:
Constanze Slabik, Maja Kalbarczyk, Simon Danisch, Reinhard Zeidler, Frank Klawonn, Valery Volk, Nicole Krönke, Friedrich Feuerhake, Constanca Ferreira de Figueiredo, Rainer Blasczyk, Henning Olbrich, Sebastian J. Theobald, Andreas Schneider, Arnold Ganser, Constantin von Kaisenberg, Stefan Lienenklaus, Andre Bleich, Wolfgang Hammerschmidt, Renata Stripecke
Publikováno v:
Molecular Therapy: Oncolytics, Vol 18, Iss , Pp 504-524 (2020)
Epstein-Barr virus (EBV) is a latent and oncogenic human herpesvirus. Lytic viral protein expression plays an important role in EBV-associated malignancies. The EBV envelope glycoprotein 350 (gp350) is expressed abundantly during EBV lytic reactivati
Externí odkaz:
https://doaj.org/article/2fc8de586f414bb99c562beadaeda7fb
Autor:
Friedrich Feuerhake, Arnold Ganser, Constantin von Kaisenberg, Nicole Krönke, Reinhard Zeidler, Constanca Figueiredo, Constanze Slabik, Wolfgang Hammerschmidt, Henning Olbrich, Rainer Blasczyk, André Bleich, Valery Volk, Frank Klawonn, Stefan Lienenklaus, Sebastian J. Theobald, Maja Kalbarczyk, Simon Danisch, Renata Stripecke, Andreas Schneider
Publikováno v:
Molecular Therapy: Oncolytics, Vol 18, Iss, Pp 504-524 (2020)
Molecular Therapy Oncolytics
Mol. Ther.-Oncolytics 18, 504-524 (2020)
Molecular therapy oncolytics
United States
Molecular Therapy Oncolytics
Mol. Ther.-Oncolytics 18, 504-524 (2020)
Molecular therapy oncolytics
United States
Epstein-Barr virus (EBV) is a latent and oncogenic human herpesvirus. Lytic viral protein expression plays an important role in EBV-associated malignancies. The EBV envelope glycoprotein 350 (gp350) is expressed abundantly during EBV lytic reactivati
Autor:
Andreas Schneider, Laura Gerasch, Henning Olbrich, Michael Mach, Thomas Shum, Constanze Slabik, Renata Stripecke, Sebastian J. Theobald, Maksim Mamonkin
Publikováno v:
Human Gene Therapy
Human cytomegalovirus (HCMV) reactivations are associated with lower overall survival after transplantations. Adoptive transfer of HCMV-reactive expanded or selected T cells can be applied as a compassionate use, but requires that the human leukocyte
Autor:
Andreas Schneider, Reinhard Zeidler, Wolfgang Hammerschmidt, Nicole Krönke, Friedrich Feuerhake, Arnold Ganser, André Bleich, Constantin von Kaisenberg, Manuel Albanese, Sebastian J. Theobald, Takanobu Tagawa, Britta Eiz-Vesper, Renata Stripecke, Simon Danisch, Stefan Lienenklaus, Yen-Fu Adam Chen, Constanze Slabik, Angela D. A. Cornelius
Publikováno v:
The American Journal of Pathology
Humanized mice developing functional human T cells endogenously and capable of recognizing cognate human leukocyte antigen–matched tumors are emerging as relevant models for studying human immuno-oncology in vivo. Herein, mice transplanted with hum
Publikováno v:
Virus Genes
Lentiviral vectors (LVs) developed in the past two decades for research and pre-clinical purposes have entered clinical trials with remarkable safety and efficacy performances. Development and clinical testing of LVs for improvement of human immunity
Autor:
Reinhard Zeidler, Friedrich Feuerhake, Arnold Ganser, Simon Danisch, Constanze Slabik, Renata Stripecke, Wolfgang Hammerschmidt
Publikováno v:
Blood. 132:2405-2405
INTRODUCTION: A promising rich pipeline of combination therapies targeting checkpoint molecules expressed on T cells and/or tumor cells is currently being developed to abrogate tumor-induced immunosuppression. Novel in vivo models suitable for valida
Publikováno v:
Blood. 132:4540-4540
Objectives: Epstein-Barr virus (EBV) is associated with lymphoproliferative disease in immunocompromised hosts and with human B-cell lymphomas and carcinomas. Adoptive transfer of virus-specific T cells is not practical when memory T cells from HLA-m